212 related articles for article (PubMed ID: 29192329)
21. Topical use of recombinant human epidermal growth factor (EGF)-based cream to prevent radiation dermatitis in breast cancer patients: a single-blind randomized preliminary study.
Kong M; Hong SE
Asian Pac J Cancer Prev; 2013; 14(8):4859-64. PubMed ID: 24083759
[TBL] [Abstract][Full Text] [Related]
22. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
23. Randomized Pilot Study of a Keratin-based Topical Cream for Radiation Dermatitis in Breast Cancer Patients.
Winkfield KM; Hughes RT; Brown DR; Clohessy RM; Holder RC; Russell GB; Rejeski AF; Burnett LR
Technol Cancer Res Treat; 2024; 23():15330338231222137. PubMed ID: 38186361
[No Abstract] [Full Text] [Related]
24. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study.
Boström A; Lindman H; Swartling C; Berne B; Bergh J
Radiother Oncol; 2001 Jun; 59(3):257-65. PubMed ID: 11369066
[TBL] [Abstract][Full Text] [Related]
25. Biophysical skin measurements to evaluate the effectiveness of photobiomodulation therapy in the prevention of acute radiation dermatitis in breast cancer patients.
Robijns J; Censabella S; Claes S; Pannekoeke L; Bussé L; Colson D; Kaminski I; Lodewijckx J; Bulens P; Maes A; Noé L; Brosens M; Timmermans A; Lambrichts I; Somers V; Mebis J
Support Care Cancer; 2019 Apr; 27(4):1245-1254. PubMed ID: 30270415
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy: A Double-Blind, Placebo-Controlled, Phase 2 Randomized Clinical Trial.
Zhao H; Zhu W; Zhao X; Li X; Zhou Z; Zheng M; Meng X; Kong L; Zhang S; He D; Xing L; Yu J
JAMA Dermatol; 2022 Jul; 158(7):779-786. PubMed ID: 35648426
[TBL] [Abstract][Full Text] [Related]
27. Novel hyaluronan formulation for preventing acute skin reactions in breast during radiotherapy: a randomized clinical trial.
Rahimi A; Mohamad O; Albuquerque K; Kim DWN; Chen D; Thomas K; Wooldridge R; Rivers A; Leitch M; Rao R; Haley B; Ahn C; Garwood D; Spangler A
Support Care Cancer; 2020 Mar; 28(3):1481-1489. PubMed ID: 31273506
[TBL] [Abstract][Full Text] [Related]
28. A double-blind, vehicle-controlled clinical study to evaluate the efficacy of MAS065D (XClair), a hyaluronic acid-based formulation, in the management of radiation-induced dermatitis.
Primavera G; Carrera M; Berardesca E; Pinnaró P; Messina M; Arcangeli G
Cutan Ocul Toxicol; 2006; 25(3):165-71. PubMed ID: 16980242
[TBL] [Abstract][Full Text] [Related]
29. Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer Patients.
Tao Y; Auperin A; Sire C; Martin M; Saliou MG; Bardet E; Sun XS; Chatellier T; Morand C; Cornely A; Angokai M; Di Rito A; Kichenin K; Blanchard P; D'Onofrio I; Bourhis J
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):590-595. PubMed ID: 29280453
[TBL] [Abstract][Full Text] [Related]
30. Effects of nanomicelle curcumin capsules on prevention and treatment of oral mucosits in patients under chemotherapy with or without head and neck radiotherapy: a randomized clinical trial.
Kia SJ; Basirat M; Saedi HS; Arab SA
BMC Complement Med Ther; 2021 Sep; 21(1):232. PubMed ID: 34521398
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of curcumin for amelioration of radiotherapy-induced oral mucositis: a preliminary randomized controlled clinical trial.
Ramezani V; Ghadirian S; Shabani M; Boroumand MA; Daneshvar R; Saghafi F
BMC Cancer; 2023 Apr; 23(1):354. PubMed ID: 37069504
[TBL] [Abstract][Full Text] [Related]
32. Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy.
Zhao H; Zhu W; Jia L; Sun X; Chen G; Zhao X; Li X; Meng X; Kong L; Xing L; Yu J
Br J Radiol; 2016; 89(1058):20150665. PubMed ID: 26607642
[TBL] [Abstract][Full Text] [Related]
33. A Randomized, Placebo-Controlled Study to Evaluate the Effect of Bio-Enhanced Turmeric Formulation on Radiation-Induced Oral Mucositis.
Soni TP; Gupta AK; Sharma LM; Singhal H; Sharma S; Gothwal RS
ORL J Otorhinolaryngol Relat Spec; 2022; 84(2):103-113. PubMed ID: 34161952
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of sesame oil versus placebo in the management of acute radiation-induced dermatitis in breast cancer patients: A double-blind randomized clinical trial.
Moslemi D; Ramezany S; Moghadamnia AA; Ebrahimian S
Asia Pac J Clin Oncol; 2023 Dec; 19(6):747-751. PubMed ID: 37620987
[TBL] [Abstract][Full Text] [Related]
35. Radiation-induced Skin Toxicity in Breast Cancer Patients: A Systematic Review of Randomized Trials.
Yee C; Wang K; Asthana R; Drost L; Lam H; Lee J; Vesprini D; Leung E; DeAngelis C; Chow E
Clin Breast Cancer; 2018 Oct; 18(5):e825-e840. PubMed ID: 30072193
[TBL] [Abstract][Full Text] [Related]
36. Melatonin for Prevention of Breast Radiation Dermatitis: A Phase II, Prospective, Double-Blind Randomized Trial.
Ben-David MA; Elkayam R; Gelernter I; Pfeffer RM
Isr Med Assoc J; 2016; 18(3-4):188-92. PubMed ID: 27228641
[TBL] [Abstract][Full Text] [Related]
37. A randomized, controlled, double-blind study of light emitting diode photomodulation for the prevention of radiation dermatitis in patients with breast cancer.
Fife D; Rayhan DJ; Behnam S; Ortiz A; Elkeeb L; Aquino L; Eduardo Roa D; Ramsinghani N; Kuo J; Newcomb R; Zachary CB; Kelly KM
Dermatol Surg; 2010 Dec; 36(12):1921-7. PubMed ID: 21070458
[TBL] [Abstract][Full Text] [Related]
38. Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study.
Schmuth M; Wimmer MA; Hofer S; Sztankay A; Weinlich G; Linder DM; Elias PM; Fritsch PO; Fritsch E
Br J Dermatol; 2002 Jun; 146(6):983-91. PubMed ID: 12072066
[TBL] [Abstract][Full Text] [Related]
39. Optimal Topical Agent for Radiation Dermatitis During Breast Radiotherapy: A Pilot Study.
Fenton-Kerimian M; Cartwright F; Peat E; Florentino R; Maisonet O; Budin W; Rolnitzky L; Formenti S
Clin J Oncol Nurs; 2015 Aug; 19(4):451-5. PubMed ID: 26207710
[TBL] [Abstract][Full Text] [Related]
40. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis.
Pignol JP; Olivotto I; Rakovitch E; Gardner S; Sixel K; Beckham W; Vu TT; Truong P; Ackerman I; Paszat L
J Clin Oncol; 2008 May; 26(13):2085-92. PubMed ID: 18285602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]